ITGAM and central nervous system cancer: To track cell type alterations induced within brain CD11b+ cells by peptide treatments, we deconvoluted bulk RNA-seq gene expression data leveraging CITE-seq transcriptomic signatures of subpopulations of CD11b+ cells from naïve and glioma-bearing brains [32] (Fig. S4B-C).